Action on Asbestos Fund Cutting Edge Technology For the Early Diagnosis of Lung Cancer

Electromagnetic Navigation Bronchoscopy (ENB)

Action on asbestos have supported the Interventional Pulmonology team at the Royal Infirmary of Edinburgh with funding of £120K to purchase advanced bronchoscopic navigation equipment for the early diagnosis of lung cancer. The equipment is called electromagnetic navigation bronchoscopy (ENB) designed by Medtronic and allows very precise access to lesions with the lung not normally accessible with a normal bronchoscope. The RIE team are the only centre in Scotland offering this service and only one of a handful in the UK.

As well as mesothelioma, asbestos exposure is associated with an increased risk of lung cancer, particularly in smokers so this technique is aimed at the early detection of lung cancer thereby optimising the chances of effective treatments for this patient group.

The Interventional Pulmonology team at the RIE are immensely grateful to AoA for their support in making this technology available and enhancing the care of our cancer patients.

IP team

Dr John McCafferty
Dr Kris Skwarski, Consultant Chest Physician
Dr Adam Marshall, Consultant Chest Physician
Dr Santiago Giavedoni, Interventional Pulmonology specialist
Mr Malcolm Will, Consultant Thoracic Surgeon

What is Asbestos-related Lung Cancer?

Statistics